Literature DB >> 19019821

Oligomeric structure of the human reduced folate carrier: identification of homo-oligomers and dominant-negative effects on carrier expression and function.

Zhanjun Hou1, Larry H Matherly.   

Abstract

The ubiquitously expressed reduced folate carrier (RFC) is the major transport system for folate cofactors in mammalian cells and tissues. Previous considerations of RFC structure and mechanism were based on the notion that RFC monomers were sufficient to mediate transport of folate and antifolate substrates. The present study examines the possibility that human RFC (hRFC) exists as higher order homo-oligomers. By chemical cross-linking, transiently expressed hRFC in hRFC-null HeLa (R5) cells with the homobifunctional cross-linker 1,3-propanediyl bis-methanethiosulfonate and Western blotting, hRFC species with molecular masses of hRFC homo-oligomers were identified. Hemagglutinin- and Myc epitope-tagged hRFC proteins expressed in R5 cells were co-immunoprecipitated from both membrane particulate and surface-enriched membrane fractions, indicating that oligomeric hRFC is expressed at the cell surface. By co-expression of wild type and inactive mutant S138C hRFCs, combined with surface biotinylation and confocal microscopy, a dominant-negative phenotype was demonstrated involving greatly decreased cell surface expression of both mutant and wild type carrier caused by impaired intracellular trafficking. For another hRFC mutant (R373A), expression of oligomeric wild type-mutant hRFC was accompanied by a significant and disproportionate loss of wild type activity unrelated to the level of surface carrier. Collectively, our results demonstrate the existence of hRFC homo-oligomers. They also establish the likely importance of these higher order hRFC structures to intracellular trafficking and carrier function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19019821      PMCID: PMC2631974          DOI: 10.1074/jbc.M807206200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  The quarternary molecular architecture of TetA, a secondary tetracycline transporter from Escherichia coli.

Authors:  C C Yin; M L Aldema-Ramos; M I Borges-Walmsley; R W Taylor; A R Walmsley; S B Levy; P A Bullough
Journal:  Mol Microbiol       Date:  2000-11       Impact factor: 3.501

Review 2.  Quaternary structure and function of transport proteins.

Authors:  Liesbeth M Veenhoff; Esther H M L Heuberger; Bert Poolman
Journal:  Trends Biochem Sci       Date:  2002-05       Impact factor: 13.807

3.  Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter.

Authors:  Larry H Matherly; Zhanjun Hou
Journal:  Vitam Horm       Date:  2008       Impact factor: 3.421

4.  Mutational analysis of the functional role of conserved arginine and lysine residues in transmembrane domains of the murine reduced folate carrier.

Authors:  I G Sharina; R Zhao; Y Wang; S Babani; I D Goldman
Journal:  Mol Pharmacol       Date:  2001-05       Impact factor: 4.436

5.  The lactose transport protein is a cooperative dimer with two sugar translocation pathways.

Authors:  L M Veenhoff; E H Heuberger; B Poolman
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

6.  Cysteine-directed cross-linking localizes regions of the human erythrocyte anion-exchange protein (AE1) relative to the dimeric interface.

Authors:  A M Taylor; Q Zhu; J R Casey
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

7.  Mechanisms of endoplasmic-reticulum export of glycine transporter-1 (GLYT1).

Authors:  Enrique Fernández-Sánchez; F Javier Díez-Guerra; Beatriz Cubelos; Cecilio Giménez; Francisco Zafra
Journal:  Biochem J       Date:  2008-02-01       Impact factor: 3.857

8.  Role of lysine 411 in substrate carboxyl group binding to the human reduced folate carrier, as determined by site-directed mutagenesis and affinity inhibition.

Authors:  Yijun Deng; Zhanjun Hou; Lei Wang; Christina Cherian; Jianmei Wu; Aleem Gangjee; Larry H Matherly
Journal:  Mol Pharmacol       Date:  2008-01-08       Impact factor: 4.436

9.  Glycine transporter dimers: evidence for occurrence in the plasma membrane.

Authors:  Ingo Bartholomäus; Laura Milan-Lobo; Annette Nicke; Sébastien Dutertre; Hanne Hastrup; Alok Jha; Ulrik Gether; Harald H Sitte; Heinrich Betz; Volker Eulenburg
Journal:  J Biol Chem       Date:  2008-02-05       Impact factor: 5.157

10.  Oligomerization of serotonin transporter and its functional consequences.

Authors:  F Kilic; G Rudnick
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  15 in total

Review 1.  Mechanisms of membrane transport of folates into cells and across epithelia.

Authors:  Rongbao Zhao; Ndeye Diop-Bove; Michele Visentin; I David Goldman
Journal:  Annu Rev Nutr       Date:  2011-08-21       Impact factor: 11.848

2.  A dominant negative heterozygous G87R mutation in the zinc transporter, ZnT-2 (SLC30A2), results in transient neonatal zinc deficiency.

Authors:  Inbal Lasry; Young Ah Seo; Hadas Ityel; Nechama Shalva; Ben Pode-Shakked; Fabian Glaser; Bluma Berman; Igor Berezovsky; Alexander Goncearenco; Aharon Klar; Jacob Levy; Yair Anikster; Shannon L Kelleher; Yehuda G Assaraf
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

3.  Association of folate receptor (FOLR1, FOLR2, FOLR3) and reduced folate carrier (SLC19A1) genes with meningomyelocele.

Authors:  Michelle R O'Byrne; Kit Sing Au; Alanna C Morrison; Jone-Ing Lin; Jack M Fletcher; Kathryn K Ostermaier; Gayle H Tyerman; Sabine Doebel; Hope Northrup
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-08

Review 4.  The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.

Authors:  Larry H Matherly; Mike R Wilson; Zhanjun Hou
Journal:  Drug Metab Dispos       Date:  2014-01-06       Impact factor: 3.922

5.  Identification and functional impact of homo-oligomers of the human proton-coupled folate transporter.

Authors:  Zhanjun Hou; Sita Kugel Desmoulin; Erika Etnyre; Mary Olive; Benjamin Hsiung; Christina Cherian; Patrick A Wloszczynski; Kamiar Moin; Larry H Matherly
Journal:  J Biol Chem       Date:  2011-12-16       Impact factor: 5.157

6.  Identification of the minimal functional unit of the homo-oligomeric human reduced folate carrier.

Authors:  Zhanjun Hou; Christina Cherian; Joseph Drews; Jianmei Wu; Larry H Matherly
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

7.  Substrate-specific binding and conformational changes involving Ser313 and transmembrane domain 8 of the human reduced folate carrier, as determined by site-directed mutagenesis and protein cross-linking.

Authors:  Zhanjun Hou; Jianmei Wu; Jun Ye; Christina Cherian; Larry H Matherly
Journal:  Biochem J       Date:  2010-09-01       Impact factor: 3.857

Review 8.  Biology of the major facilitative folate transporters SLC19A1 and SLC46A1.

Authors:  Zhanjun Hou; Larry H Matherly
Journal:  Curr Top Membr       Date:  2014       Impact factor: 3.049

9.  Cerebral folate receptor autoantibodies in autism spectrum disorder.

Authors:  R E Frye; J M Sequeira; E V Quadros; S J James; D A Rossignol
Journal:  Mol Psychiatry       Date:  2012-01-10       Impact factor: 15.992

Review 10.  The human proton-coupled folate transporter: Biology and therapeutic applications to cancer.

Authors:  Sita Kugel Desmoulin; Zhanjun Hou; Aleem Gangjee; Larry H Matherly
Journal:  Cancer Biol Ther       Date:  2012-09-06       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.